Back to Search
Start Over
Predicting clinical progression in multiple sclerosis after 6 and 12 years
- Source :
- European Journal of Neurology, Dekker, I, Eijlers, A J C, Popescu, V, Balk, L J, Vrenken, H, Wattjes, M P, Uitdehaag, B M J, Killestein, J, Geurts, J J G, Barkhof, F & Schoonheim, M M 2019, ' Predicting clinical progression in multiple sclerosis after 6 and 12 years ', European Journal of Neurology, vol. 26, no. 6, pp. 893-902 . https://doi.org/10.1111/ene.13904, European Journal of Neurology, 26(6), 893-902. Wiley-Blackwell
- Publication Year :
- 2019
- Publisher :
- John Wiley and Sons Inc., 2019.
-
Abstract
- Background and purpose: To predict disability and cognition in multiple sclerosis (MS) after 6 and 12 years, using early clinical and imaging measures. Methods: A total of 115 patients with MS were selected and followed up after 2 and 6 years, with 79 patients also being followed up after 12 years. Disability was measured using the Expanded Disability Status Scale (EDSS); cognition was measured only at follow-up using neuropsychological testing. Predictors of interest included EDSS score, baseline brain and lesion volumes and their changes over 2 years, baseline age, clinical phenotype, sex and educational level. Results: Higher 6-year EDSS score was predicted by early EDSS score and whole-brain volume changes and baseline diagnosis of primary progressive MS (adjusted R 2 = 0.56). Predictors for 12-year EDSS score included larger EDSS score changes and higher T1-hypointense lesion volumes (adjusted R 2 = 0.38). Year 6 cognition was predicted by primary progressive MS phenotype, lower educational level, male sex and early whole-brain atrophy (adjusted R 2 = 0.26); year 12 predictors included male sex, lower educational level and higher baseline T1-hypointense lesion volumes (adjusted R 2 = 0.14). Conclusions: Patients with early signs of neurodegeneration and a progressive disease onset were more prone to develop both disability progression and cognitive dysfunction. Male sex and lower educational level only affected cognitive dysfunction, which remains difficult to predict and probably needs more advanced imaging measures.
- Subjects :
- cognition
Adult
Male
medicine.medical_specialty
Multiple Sclerosis
Neuropsychological Tests
Primary progressive
Lesion
03 medical and health sciences
0302 clinical medicine
Atrophy
atrophy
Internal medicine
medicine
Humans
030212 general & internal medicine
Expanded Disability Status Scale
business.industry
Multiple sclerosis
Brain
Cognition
Original Articles
prediction
Middle Aged
medicine.disease
Magnetic Resonance Imaging
White Matter
Neurology
disability
Disease Progression
Original Article
Female
Neurology (clinical)
medicine.symptom
business
Cognition Disorders
030217 neurology & neurosurgery
Progressive disease
Clinical progression
Follow-Up Studies
Subjects
Details
- Language :
- English
- ISSN :
- 14681331 and 13515101
- Volume :
- 26
- Issue :
- 6
- Database :
- OpenAIRE
- Journal :
- European Journal of Neurology
- Accession number :
- edsair.doi.dedup.....705d2a8798677b82d0bd0002d5603aa0
- Full Text :
- https://doi.org/10.1111/ene.13904